View Item 

Show simple item record

Functions of the complement components C3 and C5 during sepsis

dc.contributor.authorFlierl, Michael A.
dc.contributor.authorRittirsch, Daniel
dc.contributor.authorNadeau, Brian A.
dc.contributor.authorDay, Danielle E.
dc.contributor.authorZetoune, Firas S.
dc.contributor.authorSarma, J. Vidya
dc.contributor.authorHuber‐lang, Markus S.
dc.contributor.authorWard, Peter A.
dc.date.accessioned2020-04-02T18:40:20Z
dc.date.available2020-04-02T18:40:20Z
dc.date.issued2008-10
dc.identifier.citationFlierl, Michael A.; Rittirsch, Daniel; Nadeau, Brian A.; Day, Danielle E.; Zetoune, Firas S.; Sarma, J. Vidya; Huber‐lang, Markus S. ; Ward, Peter A. (2008). "Functions of the complement components C3 and C5 during sepsis." The FASEB Journal 22(10): 3483-3490.
dc.identifier.issn0892-6638
dc.identifier.issn1530-6860
dc.identifier.urihttps://hdl.handle.net/2027.42/154678
dc.publisherFederation of American Societies for Experimental Biology
dc.publisherWiley Periodicals, Inc.
dc.subject.othersurvival
dc.subject.otherchemokines
dc.subject.othercolony- forming units
dc.subject.otherCH- 50
dc.subject.othercytokines
dc.titleFunctions of the complement components C3 and C5 during sepsis
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelBiology
dc.subject.hlbtoplevelScience
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154678/1/fsb2fj08110595.pdf
dc.identifier.doi10.1096/fj.08-110595
dc.identifier.sourceThe FASEB Journal
dc.identifier.citedreferenceRittirsch, D., Hoesel, L. M., and Ward, P. A. ( 2007 ) The disconnect between animal models of sepsis and human sepsis. J. Leukoc. Biol. 81, 137 - 143
dc.identifier.citedreferenceLeinhase, I., Rozanski, M., Harhausen, D., Thurman, J. M., Schmidt, O. I., Hossini, A. M., Taha, M. E., Rittirsch, D., Ward, P. A., Holers, V. M., Ertel, W., and Stahel, P. F. ( 2007 ) Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti- factor B antibody: a randomized placebo- controlled study in mice. J. Neuroinflamm. 4, 13
dc.identifier.citedreferenceHuber- Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., Gebhard, F., Younger, J. G., Drouin, S. M., Wetsel, R. A., and Ward, P. A. ( 2006 ) Generation of C5a in the absence of C3: a new complement activation pathway. Nat. Med. 12, 682 - 687
dc.identifier.citedreferenceVan Dijk, H., Rademaker, P. M., and Willers, J. M. ( 1980 ) Estimation of classical pathway of mouse complement activity by use of sensitized rabbit erythrocytes. J. Immunol. Methods 39, 257 - 268
dc.identifier.citedreferenceRittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber- Lang, M., Mackay, C. R., Zetoune, F. S., Gerard, N. P., Cianflone, K., Koehl, J., Gerard, C., Sarma, J. V., and Ward, P. A. ( 2008 ) Functional roles of C5a receptors in sepsis. Nat. Med. 14, 551 - 557
dc.identifier.citedreferenceNewman, S. L., and Mikus, L. K. ( 1985 ) Deposition of C3b and iC3b onto particulate activators of the human complement system: quantitation with monoclonal antibodies to human C3. J. Exp. Med. 161, 1414 - 1431
dc.identifier.citedreferenceGasque, P. ( 2004 ) Complement: a unique innate immune sensor for danger signals. Mol. Immunol. 41, 1089 - 1098
dc.identifier.citedreferenceMollnes, T. E., Brekke, O. L., Fung, M., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegard, K. T., Kohl, J., and Lambris, J. D. ( 2002 ) Essential role of the C5a receptor in E coli- induced oxidative burst and phagocytosis revealed by a novel lepirudin- based human whole blood model of inflammation. Blood 100, 1869 - 1877
dc.identifier.citedreferenceBrekke, O. L., Christiansen, D., Fure, H., Fung, M., and Mollnes, T. E. ( 2007 ) The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli- induced up- regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J. Leukoc. Biol. 81, 1404 - 1413
dc.identifier.citedreferenceBuras, J. A., Rice, L., Orlow, D., Pavlides, S., Reenstra, W. R., Ceonzo, K., and Stahl, G. L. ( 2004 ) Inhibition of C5 or absence of C6 protects from sepsis mortality. Immunobiology 209, 629 - 635
dc.identifier.citedreferenceEbong, S. J., Call, D. R., Bolgos, G., Newcomb, D. E., Granger, J. I., O’Reilly, M., and Remick, D. G. ( 1999 ) Immunopathologic responses to non- lethal sepsis. Shock 12, 118 - 126
dc.identifier.citedreferenceRemick, D. G., Newcomb, D. E., Bolgos, G. L., and Call, D. R. ( 2000 ) Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13, 110 - 116
dc.identifier.citedreferenceRemick, D. G., and Ward, P. A. ( 2005 ) Evaluation of endotoxin models for the study of sepsis. Shock 24 ( Suppl. 1 ), 7 - 11
dc.identifier.citedreferenceAlper, C. A., Colten, H. R., Rosen, F. S., Rabson, A. R., Macnab, G. M., and Gear, J. S. ( 1972 ) Homozygous deficiency of C3 in a patient with repeated infections. Lancet 2, 1179 - 1181
dc.identifier.citedreferenceAlper, C. A., Colten, H. R., Gear, J. S., Rabson, A. R., and Rosen, F. S. ( 1976 ) Homozygous human C3 deficiency: the role of C3 in antibody production, C- 1s- induced vasopermeability, and cobra venom- induced passive hemolysis. J. Clin. Investig. 57, 222 - 229
dc.identifier.citedreferenceRosenfeld, S. I., Kelly, M. E., and Leddy, J. P. ( 1976 ) Hereditary deficiency of the fifth component of complement in man: I. Clinical, immunochemical, and family studies. J. Clin. Investig. 57, 1626 - 1634
dc.identifier.citedreferenceBone, R. C. ( 1996 ) Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 125, 680 - 687
dc.identifier.citedreferenceBone, R. C. ( 1996 ) Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit. Care Med. 24, 163 - 172
dc.identifier.citedreferenceRemick, D. G. ( 2003 ) Cytokine therapeutics for the treatment of sepsis: why has nothing worked? Curr. Pharm. Des. 9, 75 - 82
dc.identifier.citedreferenceGerard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., and Velu, T. ( 1993 ) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177, 547 - 550
dc.identifier.citedreferenceSantucci, L., Fiorucci, S., Chiorean, M., Brunori, P. M., Di Matteo, F. M., Sidoni, A., Migliorati, G., and Morelli, A. ( 1996 ) Interleukin 10 reduces lethality and hepatic injury induced by lipopolysaccharide in galactosamine- sensitized mice. Gastroenterology 111, 736 - 744
dc.identifier.citedreferenceBerg, D. J., Kuhn, R., Rajewsky, K., Muller, W., Menon, S., Davidson, N., Grunig, G., and Rennick, D. ( 1995 ) Interleukin- 10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Schwartzmann reaction but not endotoxin tolerance. J. Clin. Investig. 96, 2339 - 2347
dc.identifier.citedreferenceAshare, A., Powers, L. S., Butler, N. S., Doerschug, K. C., Monick, M. M., and Hunninghake, G. W. ( 2005 ) Anti- inflammatory response is associated with mortality and severity of infection in sepsis. Am. J. Physiol. Lung Cell Mol. Physiol. 288, L633 - L640
dc.identifier.citedreferenceWang, Q., Wang, J. J., Fischer, J. E., and Hasselgren, P. O. ( 1998 ) Mucosal production of complement C3 and serum amyloid A is differentially regulated in different parts of the gastrointestinal tract during endotoxemia in mice. J. Gastrointest. Surg. 2, 537 - 546
dc.identifier.citedreferenceYang, H., Tuzun, E., Alagappan, D., Yu, X., Scott, B. G., Ischenko, A., and Christadoss, P. ( 2005 ) IL- 1 receptor antagonist- mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti- acetylcholine receptor IgG1. J. Immunol. 175, 2018 - 2025
dc.identifier.citedreferenceOsuchowski, M. F., Welch, K., Yang, H., Siddiqui, J., and Remick, D. G. ( 2007 ) Chronic sepsis mortality characterized by an individualized inflammatory response. J. Immunol. 179, 623 - 630
dc.identifier.citedreferenceSprong, T., Brandtzaeg, P., Fung, M., Pharo, A. M., Hoiby, E. A., Michaelsen, T. E., Aase, A., van der Meer, J. W., van Deuren, M., and Mollnes, T. E. ( 2003 ) Inhibition of C5a- induced inflammation with preserved C5b- 9- mediated bactericidal activity in a human whole blood model of meningococcal sepsis. Blood 102, 3702 - 3710
dc.identifier.citedreferenceRiedemann, N. C., Guo, R. F., and Ward, P. A. ( 2003 ) The enigma of sepsis. J. Clin. Investig. 112, 460 - 467
dc.identifier.citedreferenceLevy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J. L., and Ramsay, G. ( 2003 ) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 31, 1250 - 1256
dc.identifier.citedreferenceAnnane, D., Bellissant, E., and Cavaillon, J. M. ( 2005 ) Septic shock. Lancet 365, 63 - 78
dc.identifier.citedreferenceDombrovskiy, V. Y., Martin, A. A., Sunderram, J., and Paz, H. L. ( 2007 ) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit. Care Med. 35, 1244 - 1250
dc.identifier.citedreferenceKochanek, K. D., and Smith, B. L. ( 2004 ) Deaths: preliminary data for 2002. Natl. Vital Stat. Rep. 52, 1 - 47
dc.identifier.citedreferenceGuo, R. F., and Ward, P. A. ( 2005 ) Role of C5a in inflammatory responses. Annu. Rev. Immunol. 23, 821 - 852
dc.identifier.citedreferenceMuller- Eberhard, H. J. ( 1988 ) Molecular organization and function of the complement system. Annu. Rev. Biochem. 57, 321 - 347
dc.identifier.citedreferenceReid, K. B., and Porter, R. R. ( 1981 ) The proteolytic activation systems of complement. Annu. Rev. Biochem. 50, 433 - 464
dc.identifier.citedreferenceGerard, C. ( 2003 ) Complement C5a in the sepsis syndrome- too much of a good thing? N. Engl. J. Med. 348, 167 - 169
dc.identifier.citedreferenceWard, P. A. ( 2004 ) The dark side of C5a in sepsis. Nat. Rev. Immunol. 4, 133 - 142
dc.identifier.citedreferenceHuber- Lang, M. S., Younkin, E. M., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Curnutte, J. T., Erickson, R., and Ward, P. A. ( 2002 ) Complement- induced impairment of innate immunity during sepsis. J. Immunol. 169, 3223 - 3231
dc.identifier.citedreferenceHuber- Lang, M., Sarma, V. J., Lu, K. T., McGuire, S. R., Padgaonkar, V. A., Guo, R. F., Younkin, E. M., Kunkel, R. G., Ding, J., Erickson, R., Curnutte, J. T., and Ward, P. A. ( 2001 ) Role of C5a in multiorgan failure during sepsis. J. Immunol. 166, 1193 - 1199
dc.identifier.citedreferenceGuo, R. F., Huber- Lang, M., Wang, X., Sarma, V., Padgaonkar, V. A., Craig, R. A., Riedemann, N. C., McClintock, S. D., Hlaing, T., Shi, M. M., and Ward, P. A. ( 2000 ) Protective effects of anti- C5a in sepsis- induced thymocyte apoptosis. J. Clin. Investig. 106, 1271 - 1280
dc.identifier.citedreferenceRiedemann, N. C., Guo, R. F., Laudes, I. J., Keller, K., Sarma, V. J., Padgaonkar, V., Zetoune, F. S., and Ward, P. A. ( 2002 ) C5a receptor and thymocyte apoptosis in sepsis. FASEB J. 16, 887 - 888
dc.identifier.citedreferenceLaudes, I. J., Chu, J. C., Sikranth, S., Huber- Lang, M., Guo, R. F., Riedemann, N., Sarma, J. V., Schmaier, A. H., and Ward, P. A. ( 2002 ) Anti- c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am. J. Pathol. 160, 1867 - 1875
dc.identifier.citedreferenceNakae, H., Endo, S., Inada, K., Takakuwa, T., Kasai, T., and Yoshida, M. ( 1994 ) Serum complement levels and severity of sepsis. Res. Commun. Chem. Pathol. Pharmacol. 84, 189 - 195
dc.identifier.citedreferenceNakae, H., Endo, S., Inada, K., and Yoshida, M. ( 1996 ) Chronological changes in the complement system in sepsis. Surg. Today 26, 225 - 229
dc.identifier.citedreferenceStove, S., Welte, T., Wagner, T. O., Kola, A., Klos, A., Bautsch, W., and Kohl, J. ( 1996 ) Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome. Clin. Diagn. Lab. Immunol. 3, 175 - 183
dc.identifier.citedreferenceHack, C. E., Nuijens, J. H., Felt- Bersma, R. J., Schreuder, W. O., Eerenberg- Belmer, A. J., Paardekooper, J., Bronsveld, W., and Thijs, L. G. ( 1989 ) Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am. J. Med. 86, 20 - 26
dc.identifier.citedreferenceCzermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber- Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., and Ward, P. A. ( 1999 ) Protective effects of C5a blockade in sepsis. Nat. Med. 5, 788 - 792
dc.identifier.citedreferenceHuber- Lang, M. S., Riedeman, N. C., Sarma, J. V., Younkin, E. M., McGuire, S. R., Laudes, I. J., Lu, K. T., Guo, R. F., Neff, T. A., Padgaonkar, V. A., Lambris, J. D., Spruce, L., Mastellos, D., Zetoune, F. S., and Ward, P. A. ( 2002 ) Protection of innate immunity by C5aR antagonist in septic mice. FASEB J. 16, 1567 - 1574
dc.identifier.citedreferenceHuber- Lang, M. S., Sarma, J. V., McGuire, S. R., Lu, K. T., Guo, R. F., Padgaonkar, V. A., Younkin, E. M., Laudes, I. J., Riedemann, N. C., Younger, J. G., and Ward, P. A. ( 2001 ) Protective effects of anti- C5a peptide antibodies in experimental sepsis. FASEB J. 15, 568 - 570
dc.identifier.citedreferenceProdeus, A. P., Zhou, X., Maurer, M., Galli, S. J., and Carroll, M. C. ( 1997 ) Impaired mast cell- dependent natural immunity in complement C3- deficient mice. Nature 390, 172 - 175
dc.identifier.citedreferenceFischer, M. B., Prodeus, A. P., Nicholson- Weller, A., Ma, M., Murrow, J., Reid, R. R., Warren, H. B., Lage, A. L., Moore, F. D., Jr., Rosen, F. S., and Carroll, M. C. ( 1997 ) Increased susceptibility to endotoxin shock in complement C3- and C4- deficient mice is corrected by C1 inhibitor replacement. J. Immunol. 159, 976 - 982
dc.identifier.citedreferenceCircolo, A., Garnier, G., Fukuda, W., Wang, X., Hidvegi, T., Szalai, A. J., Briles, D. E., Volanakis, J. E., Wetsel, R. A., and Colten, H. R. ( 1999 ) Genetic disruption of the murine complement C3 promoter region generates deficient mice with extra- hepatic expression of C3 mRNA. Immunopharmacology 42, 135 - 149
dc.identifier.citedreferenceBaker, C. C., Chaudry, I. H., Gaines, H. O., and Baue, A. E. ( 1983 ) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94, 331 - 335
dc.identifier.citedreferenceBora, P. S., Sohn, J. H., Cruz, J. M., Jha, P., Nishihori, H., Wang, Y., Kaliappan, S., Kaplan, H. J., and Bora, N. S. ( 2005 ) Role of complement and complement membrane attack complex in laser- induced choroidal neovascularization. J. Immunol. 174, 491 - 497
dc.identifier.citedreferenceLeinhase, I., Holers, V. M., Thurman, J. M., Harhausen, D., Schmidt, O. I., Pietzcker, M., Taha, M. E., Rittirsch, D., Huber- Lang, M., Smith, W. R., Ward, P. A., and Stahel, P. F. ( 2006 ) Reduced neuronal cell death after experimental brain injury in mice lacking a functional alternative pathway of complement activation. BMC Neurosci. 7, 55
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
fsb2fj08110595.pdf
Size:
422.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.